|
1
|
Smith JA and Woodcock A: Chronic cough. N
Engl J Med. 376:183–184. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chung KF: IFN-γ: A driver of cough
hypersensitivity pathways in chronic cough. Am J Respir Crit Care
Med. 198:827–828. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Herregods TVK, Pauwels A, Jafari J, Sifrim
D, Bredenoord AJ, Tack J and Smout AJPM: Determinants of
Reflux-induced chronic cough. Gut. 66:2057–2062. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Song WJ, Kim HJ, Shim JS, Won HK, Kang SY,
Sohn KH, Kim BK, Jo EJ, Kim MH, Kim SH, et al: Diagnostic accuracy
of fractional exhaled nitric oxide measurement in predicting
cough-variant asthma and eosinophilic bronchitis in adults with
chronic cough: A systematic review and meta-analysis. J Allergy
Clin Immunol. 140:701–709. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gibson P, Wang G, McGarvey L, Vertigan AE,
Altman KW and Birring SS: Treatment of Unexplained Chronic Cough:
CHEST guideline and expert panel report. Chest. 149:27–44.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Millqvist E: The problem of treating
unexplained chronic cough. Chest. 149:613–614. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Abdulqawi R, Dockry R, Holt K, Layton G,
McCarthy BG, Ford AP and Smith JA: P2X3 receptor antagonist
(AF-219) in refractory chronic cough: A randomised, Double-blind,
Placebo-controlled phase 2 study. Lancet. 385:1198–1205.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gopal AK, Schuster SJ, Fowler NH, Trotman
J, Hess G, Hou JZ, Yacoub A, Lill M, Martin P, Vitolo U, et al:
Ibrutinib as treatment for patients with relapsed/refractory
follicular lymphoma: Results from the open-label, multicenter,
phase II DAWN study. J Clin Oncol. 36:2405–2412. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Smith JA, Haines J and Yorke J: Taming
chronic cough. Thorax. 72:103–104. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kalhan R, Dransfield MT, Colangelo LA,
Cuttica MJ, Jacobs DR Jr, Thyagarajan B, Estepar RSJ, Harmouche R,
Onieva JO, Ash SY, et al: Respiratory symptoms in young adults and
future lung disease The CARDIA lung study. Am J Respir Crit Care
Med. 197:1616–1624. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Choi IJ, Kim YI and Park B:
Helicobacter pylori and prevention of gastric cancer. N Engl
J Med. 378:2244–2245. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Abbasi J: Barry marshall and MD: H
pylori 35 Years Later. JAMA. 317:1400–1402. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ehrlich D, Naini B and Mukewar S: A rare
cause of gastric wall thickening. Gastroenterology. 154:e18–e20.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Koch KN, Hartung ML, Urban S, Kyburz A,
Bahlmann AS, Lind J, Backert S, Taube C and Müller A: Helicobacter
urease-induced activation of the TLR2/NLRP3/IL-18 Axis protects
against asthma. J Clin Invest. 125:3297–302. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Talaat M, Gad MS, Magdy EA, Aggag SM and
Nour YA: Helicobacter pylori infection and chronic,
persistent cough: Is there an association. J Laryngol Otol.
121:962–7. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang L, Guan Y, Li Y, Liu X, Zhang Y, Wang
F, Kong L and Guo Q: Association between chronic respiratory
diseases and Helicobacter pylori: A meta-analysis. Arch
Bronconeumol. 51:273–278. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kreuter M, Kirsten D, Bahmer T, Penzel R,
Claussen M, Ehlers-Tenenbaum S, Muley T, Palmowski K, Eichinger M,
Leider M, et al: Screening for Helicobacter pylori in
idiopathic pulmonary fibrosis lung biopsies. Respiration. 91:3–8.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hong L, Li S, Feng Q, Feng X, Jin Y, Zhao
Q and Zhang H: H. pylori infection may cause sleep-related
laryngospasm for a patient in climacteric. J Pain Symptom Manage.
39:e6–e7. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kefang Lai, et al: Guidelines for
diagnosis and treatment of cough (2015). Chinese Journal of
Tuberculosis and Respiratory Diseases: 323-354, 2016.
|
|
20
|
Liou JM, Fang YJ, Chen CC, Bair MJ, Chang
CY, Lee YC, Chen MJ, Chen CC, Tseng CH, Hsu YC, et al: Concomitant,
bismuth quadruple, and 14-day triple therapy in the First-line
treatment of Helicobacter pylori: A multicentre, Open-label,
randomised trial. Lancet. 388:2355–2365. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chey WD, Leontiadis GI, Howden CW and Moss
SF: ACG Clinical Guideline: Treatment of Helicobacter pylori
Infection. Am J Gastroenterol. 112:212–239. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhao RY, Zhu L, Li L, Chen Q and Yang YJ:
The applicability of the 1988 version of the prediction equations
for adult normal lung function in Shanghai. Zhonghua Jie He He Hu
Xi Za Zhi. 34:586–589. 2011.PubMed/NCBI(In Chinese).
|
|
23
|
Parsonnet J:
Clinician-discoverers-Marshall, Warren, and H. pylori. N
Engl J Med. 353:2421–2423. 2005.
|
|
24
|
Lanas A and Chan FKL: Peptic ulcer
disease. Lancet. 390:613–624. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kim IJ, Lee J, Oh SJ, Yoon MS, Jang SS,
Holland RL, Reno ML, Hamad MN, Maeda T, Chung HJ, et al:
Helicobacter pylori Infection modulates host cell metabolism
through VacA-dependent inhibition of mTORC1. Cell Host Microbe.
23:583–593.e8. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kariya S, Okano M and Nishizaki K: An
Association between Helicobacter pylori and upper
respiratory tract disease: Fact or fiction. World J Gastroenterol.
20:1470–1484. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
De Korwin JD, Ianiro G, Gibiino G and
Gasbarrini A: Helicobacter pylori infection and extragastric
diseases in 2017. Helicobacter: 22 (Suppl 1), 2017 doi:
10.1111/hel.12411.
|
|
28
|
Gülhan M, Ozyilmaz E, Tarhan G, Demirağ F,
Capan N, Ertürk A, Canbakan S, Ayaşlioğlu E, Gülhan E and Ahmed K:
Helicobacter pylori in bronchiectasis: A polymerase chain
reaction assay in bronchoalveolar lavage fluid and bronchiectatic
lung tissue. Arch Med Res. 38:317–321. 2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
El-Serag HB, Kao JY, Kanwal F, Gilger M,
LoVecchio F, Moss SF, Crowe SE, Elfant A, Haas T, Hapke RJ and
Graham DY: Houston consensus conference on testing for
Helicobacter pylori Infection in the United states. clin
gastroenterol hepatol. 16:992–1002.e6. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Rossi AF, Cadamuro AC, Biselli-Perico JM,
Leite KR, Severino FE, Reis PP, Cordeiro JA and Silva AE:
Interaction between inflammatory mediators and miRNAs in
Helicobacter pylori Infection. Cell Microbiol. 18:1444–1458.
2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Barrozo RM, Hansen LM, Lam AM, Skoog EC,
Martin ME, Cai LP, Lin Y, Latoscha A, Suerbaum S, Canfield DR, et
al: CagY is an Immune-sensitive regulator of the Helicobacter
pylori type iv secretion system. Gastroenterology.
151:1164–1175.e3. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
D'Elios MM, Montecucco C and de Bernard M:
VacA and HP-NAP, Ying and Yang of Helicobacter
pylori-associated gastric inflammation. Clin Chim Acta.
381:32–38. 2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ramachandran M, Jin C, Yu D, Eriksson F
and Essand M: Vector-encoded Helicobacter pylori
neutrophil-activating protein promotes maturation of dendritic
cells with Th1 polarization and Improved Migration. J Immunol.
193:2287–2296. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Nakashima S, Kakugawa T, Yura H, Tomonaga
M, Harada T, Hara A, Hara S, Nakano M, Yamasaki E, Sakamoto N, et
al: Identification of Helicobacter pylori vaca in human lung
and its effects on lung cells. Biochem Biophys Res Commun.
460:721–726. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Montecucco C and de Bernard M:
Immunosuppressive and proinflammatory activities of the VacA Toxin
of Helicobacter pylori. J Exp Med. 198:1767–1771.
2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Fullerton D, Britton JR, Lewis SA, Pavord
ID, McKeever TM and Fogarty AW: Helicobacter pylori and lung
function, asthma, atopy and allergic disease-a population-based
cross-sectional study in adults. Int J Epidemiol. 38:419–426.
2009.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Gencer M, Ceylan E, Yildiz ZF and Aksoy N:
Helicobacter pylori seroprevalence in patients with chronic
obstructive pulmonary disease and its relation to pulmonary
function tests. Respiration. 74:170–175. 2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sze MA, Chen YW, Tam S, Tashkin D, Wise
RA, Connett JE, Man SP and Sin DD: The relationship between
Helicobacter pylori Seropositivity and COPD. Thorax.
70:923–929. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fogarty AW: Does Helicobacter
pylori Infection modify lung development, height or simply
reflect shared environmental exposures. Thorax.
70(918)2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai
C, Kang J, Ran P, Shen H, Wen F, et al: China pulmonary health
study group Prevalence and risk factors of chronic obstructive
pulmonary disease in China (the China Pulmonary Health [CPH]
study): A national Cross-sectional study. Lancet. 391:1706–1717.
2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Taye B, Enquselassie F, Tsegaye A,
Amberbir A, Medhin G, Fogarty A, Robinson K and Davey G:
Association between infection with Helicobacter pylori and
atopy in young ethiopian children: A longitudinal study. Clin Exp
Allergy. 47:1299–1308. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Engler DB, Reuter S, van Wijck Y, Urban S,
Kyburz A, Maxeiner J, Martin H, Yogev N, Waisman A, Gerhard M, et
al: Effective treatment of allergic airway inflammation with
Helicobacter pylori immunomodulators requires
BATF3-dependent dendritic cells and IL-10. Proc Natl Acad Sci USA.
111:11810–11815. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
van Wijck Y, de Kleijn S, John-Schuster G,
Mertens TCJ, Hiemstra PS, Müller A, Smits HH and Taube C:
Therapeutic application of an extract of Helicobacter pylori
ameliorates the development of allergic airway disease. J Immunol.
200:1570–1579. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lim JH, Kim N, Lim SH, Kwon JW, Shin CM,
Chang YS, Kim JS, Jung HC and Cho SH: Inverse relationship between
Helicobacter pylori infection and asthma among adults
younger than 40 years: A cross-sectional study. Medicine
(Baltimore). 95(e2609)2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
van Wijck Y, John-Schuster G, van
Schadewijk A, van den Oever RL, Obieglo K, Hiemstra PS, Müller A,
Smits HH and Taube C: Extract of Helicobacter pylori
ameliorates parameters of airway inflammation and goblet cell
hyperplasia following repeated allergen exposure. Int Arch Allergy
Immunol. 180:1–9. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lee SP, Lee SY, Kim JH, Sung IK, Park HS,
Shim CS and Moon HW: Correlation between Helicobacter pylori
Infection, IgE hypersensitivity, and allergic disease in korean
adults. Helicobacter. 20:49–55. 2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Amberbir A, Medhin G, Abegaz WE, Hanlon C,
Robinson K, Fogarty A, Britton J, Venn A and Davey G: Exposure to
Helicobacter pylori infection in early childhood and the
risk of allergic disease and atopic sensitization: A longitudinal
birth cohort study. Clin Exp Allergy. 44:563–571. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Leppold C, Tanimoto T, Ozaki A, Morita T
and Sari PV: Helicobacter pylori Vaccination. Lancet.
387:748–749. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Liu H, Liu W, Tan Z, Zeng Z, Yang H, Luo
S, Wang L, Xi T and Xing Y: Promoting immune efficacy of the oral
Helicobacter pylori Vaccine by HP55/PBCA nanoparticles
against the gastrointestinal environment. Mol Pharm. 15:3177–3186.
2018.PubMed/NCBI View Article : Google Scholar
|
